基本信息
出版地:UNITED STATES
期刊简称:J NEUROIMMUNE PHARM
通讯地址:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
创刊年份:2006
发行周期:Quarterly
涉及方向:医学 - 神经科学
ESSN:1557-1904
英文期刊简介
The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.
中文期刊简介
《Journal Of Neuroimmune Pharmacology》是一本由SPRINGER出版商出版的专业医学期刊，该刊创刊于2006年，刊期Quarterly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：神经科学 3区；药学 3区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖神经科学等领域，旨在及时、准确、全面地报道国内外神经科学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为7.285，平均审稿速度较慢,6-12周。
